您现在的位置是:【微信950216】欧博公司客服怎么联系 > 百科
Weight regain happens 4x faster after stopping GLP
【微信950216】欧博公司客服怎么联系2026-02-01 02:45:48【百科】3人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(89)
上一篇: 乡镇到泰安考察学习报告
下一篇: 外国名人故事:贝尔的名人故事 4
相关文章
- 悲催PC玩家!有分析称2026年可能会进入一个“没有GPU的地狱”
- 剑侠世界起源手游职业推荐攻略
- 韩国总统李在明结束访华
- Chappell Roan walks back Brigitte Bardot tribute after fan backlash
- 领先技术 在水处理行业双剑出击
- 对决剑之川外攻队玩法搭配分享
- 0比0战平伊拉克队 U23国足首战抢到1分
- Lễ tổng kết và trao giải cuộc thi viết 'Thanh Niên và tôi': Nhắc nhớ hành trình 40 năm
- 慢性肾炎的症状表现
- 七日世界礼包码大全 七日世界礼包码在哪兑换
热门文章
站长推荐
友情链接
- 张雨绮婚讯公开 感恩关心收获祝福
- 中国水网:黄江龙:膜技术应用于污水资源化领域不仅技术先进 而且经济可行
- 李玉玺再发全创作专辑 MV《Goodbye My Lover》今日首播
- WCBA总决赛:内蒙古女篮终结四川女篮20连胜 1
- 2024最新传奇手游排行榜前十名有哪些 2024最新传奇手游推荐
- 银河通用机器人获21亿元新融资,估值超210亿元
- 京东健康发起2026年亿元品牌联盟
- 润肺的食物有哪些? 9种润肺的食物帮你保护好肺
- 幼儿园外墙设计技巧 幼儿园装修注意事项
- 盐田区 2024 年 11.8 垃圾减量日“换享市集” 主题宣传活动
- 现代家居装修效果图大全 现代家居装饰特点
- China exploiting birthright citizenship to gain leverage in US, Schweizer warns
- 天常股份(300728)暂缓上市发行 A股之路蒙上阴影
- 中国又搞出黑科技了 双·11全网销售战绩有“鲁班”功劳
- 当辣条遇到糖葫芦? 除了冰糖辣条中国还有哪些黑暗料理?
- 室内装修颜色搭配墙面颜色 室内装修木工知识
- 中国水网:连续三年跻身“中国环境企业50强”第一方阵
- 绘海报、走社区 杭州伢儿们挨家挨户宣传环保理念
- 英超积分榜:曼城重返胜利轨道 曼联若成功阻击阿森纳进前四
- 《人民日报》头版:水质更洁净 饮水更安全(新数据 新看点)







